loadpatents
Patent applications and USPTO patent grants for DOERNER; Achim.The latest application filed is for "bi-specific antibodies for enhanced tumor selectivity and inhibition and uses thereof".
Patent | Date |
---|---|
Bi-specific Antibodies For Enhanced Tumor Selectivity And Inhibition And Uses Thereof App 20220111064 - DOERNER; Achim ;   et al. | 2022-04-14 |
Bi-specific antibodies for enhanced tumor selectivity and inhibition and uses thereof Grant 11,235,063 - Doerner , et al. February 1, 2 | 2022-02-01 |
Anti-c-met Antibodies And Antibody Drug Conjugates Thereof For Efficient Tumor Inhibition App 20190248907 - DOERNER; Achim ;   et al. | 2019-08-15 |
Bi-specific Antibodies For Enhanced Tumor Selectivity And Inhibition And Uses Thereof App 20180326085 - DOERNER; Achim ;   et al. | 2018-11-15 |
Bispecific aptamers mediating tumour cell lysis Grant 8,969,318 - Toleikis , et al. March 3, 2 | 2015-03-03 |
Bispecific Aptamers Mediating Tumour Cell Lysis App 20140039042 - Toleikis; Lars ;   et al. | 2014-02-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.